Sign In  |  Register  |  About Walnut Creek Guide  |  Contact Us

Walnut Creek, CA
September 01, 2020 1:43pm
7-Day Forecast | Traffic

  • Search Hotels in Walnut Creek Guide

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Illumina Inc (NQ: ILMN )

143.82 +3.68 (+2.63%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 25, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Illumina Inc

< Previous 1 2 3 4 5 6 7 8 9
...
29 30 Next >
EU Antitrust Regulators Overstepped in Illumina-Grail Deal, Says Court Adviser
EU antitrust advisor criticizes decision blocking Illumina's $7.1 billion bid for Grail, citing overreach. Impact on Qualcomm deal scrutinized. Commission's jurisdiction challenged amid legal battles.... 
Via Benzinga
Leading the Way: Swoop Named Provider of Choice for Employee Shuttling by Fortune 500 & Renowned Technology Companies
LOS ANGELES - March 20, 2024 - PRLog -- Swoop Inc. the leading group transportation service provider, is proud to announce its recent success in providing best-in-class employee shuttling services to... 
Via PRLog
Critical Insights From Illumina Analyst Ratings: What You Need To Know
Via Benzinga
Earnings Scheduled For February 8, 2024
Companies Reporting Before The Bell • Ares Management (NYSE:ARES) is expected to report quarterly earnings at $1.09 per share on revenue of $864.54 million. 
Via Benzinga
Earnings Preview For Illumina
Via Benzinga
(ILMN) - Analyzing Illumina's Short Interest
Via Benzinga
Icahn’s All-In: 3 Stocks Billionaire Carl Icahn Is Betting Big On
Carl Icahn, the corporate raider turned activist investor, has put most of his master limited partnership' portfolio into just three stocks. 
Via InvestorPlace
Gene Sequencing Firm Illumina Escapes Carl Icahn's Second Proxy Battle Amid Grail Divestment Efforts
Carl Icahn halts new challenge to Illumina's board, sparing the gene sequencing giant a second proxy battle. Focus shifts to legal action over Grail acquisition. 
Via Benzinga
Earnings Crushers: Unveiling Q4’s 3 Top Stock Superstars
Although there were many earnings winners in the fourth quarter, these three picks have more promise than their counterparts. 
Via InvestorPlace
3 Cancer-Fighting Biotech Stocks Showing Clinical Trial Promise
Discover the pivotal roles of cancer-fighting biotech stocks that are advancing cancer research and subsequently, their financial growth. 
Via InvestorPlace
7 No-Frills Dividend Stocks for Your Must-Own List
Income investors don't need to invest in risky businesses when no-frills dividend stocks get the job done just fine. 
Via InvestorPlace
Analyst Ratings For Illumina
Via Benzinga
Over $1M Bet On This Industrial Stock? Check Out These 4 Stocks Insiders Are Buying
Although U.S. stocks closed lower on Monday, there were a few notable insider trades. 
Via Benzinga
ILLUMINA ALERT: Bragar Eagel & Squire, P.C. is Investigating Illumina, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Why Illumina Stock Mashed the Market on Monday
Investors usually get more bullish when a top manager buys more heavily into their company. 
Via The Motley Fool
Activist Investor Alert: The Top 3 Stocks Carl Icahn Is Targeting in 2024
For those who want to invest alongside the legendary financier and activist investor, these are the top Carl Icahn stocks right now. 
Via InvestorPlace
3 Gene Editing Stocks With Unprecedented Surge Potential
While CRISPR will certainly be exciting to watch, here are some other gene-editing stocks with unprecedented surge potential. 
Via InvestorPlace
Why Take-Two Interactive Software Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Shares of Take-Two Interactive Software, Inc. (NASDAQ: TTWO) fell sharply during Friday’s session following third-quarter results. 
Via Benzinga
DNA Sequencing Kit Provider Illumina's Q4 Earnings Edge Above Street Estimates, Works To Resolve GRAIL Quickly
Illumina exceeds Q4 2023 expectations with $1.12 billion sales, up 4% YoY. CEO Jacob Thaysen anticipates growth and outlines strategic priorities for 2024. 
Via Benzinga
US Stocks Set To Open Higher, Finish Week Stronger Amid Mixed Earnings: Analyst Sees Another Leg-Up Ahead Of Historically Weak March
The upward momentum that has been in play in recent sessions could cushion the market, especially as most major indices are in uncharted territory. 
Via Benzinga
Expedia Reports Q4 Results, Joins Pinterest, Affirm Holdings And Other Big Stocks Moving Lower In Friday's Pre-Market Session
U.S. stock futures were mixed this morning, with the Dow futures trading lower by around 15 points on Friday. 
Via Benzinga
Topics Stocks
Exposures US Equities
S&P 500 Tests Resistance At 5,000, ARM Rockets, Oil Rebounds: What's Driving Markets Thursday?
Major U.S. stock averages traded on a mixed note at midday in New York, with the S&P 500 grappling with the psychological resistance level of 5,000, while the tech-heavy Nasdaq 100 managed to reach... 
Via Benzinga
Topics Stocks
Exposures US Equities
US Stocks On Backfoot Amid Overbought Levels, S&P 500 Eyes Break Above 5K: Analyst Sees 'Dramatically Higher' Market Surge From Rally This Year
Focus now shifts to the jobless claims report for labor market insights, with market overbought levels prompting a defensive stance. 
Via Benzinga
Topics Stocks
Exposures US Equities
The Top 25 Stocks to Buy Immediately According to AI: February 2024 Edition
Some of the best stocks to buy in February according to MarketMaster AI suggest that a major economic recovery is underway. 
Via InvestorPlace
Topics Artificial Intelligence
Exposures Artificial Intelligence
Fall in Love with ‘Galaxy 360: A Woman’s Playground’ this Valentine’s Day
Via Get News
Top Stock Picks 2024: 3 Healthcare Stocks Leading Medical Advancements
Discover how emerging tech is shaping healthcare stocks in 2024. See which companies are outperforming and what it means for your portfolio. 
Via InvestorPlace
Tuesday Talk: A Good Month - Two Days To Go
With two trading days to go in January the major stock indices seem to be set to end the month at new highs and there are fewer analysts trying to insist that the 
Via Talk Markets
3 Stocks to Buy for the Age of Personalized Medicine
Personalized medicine stocks can unlock significant growth from your portfolio. Here are three companies to consider. 
Via InvestorPlace
Jim Cramer: Stay Away From This Major Airline Stock, 'People Should Understand Airlines Are Trades'
On CNBC’s "Mad Money Lightning Round," Jim Cramer recommended to stay away from Delta Air Lines, Inc. (NYSE: DAL). "People should understand airlines are trades," he noted. 
Via Benzinga
MarketBeat ‘Stock of the Week’: Intuitive Surgical hits new highs
With recent obesity drug fears proving to be overblown and equipment placements growing, expect ISRG to reward growth investors with plenty more record highs. 
Via MarketBeat
Topics Earnings
Exposures Financial
< Previous 1 2 3 4 5 6 7 8 9
...
29 30 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 WalnutCreekGuide.com & California Media Partners, LLC. All rights reserved.